Genes involved in glucose metabolism were used as surrogate markers in different gene signatures to prognosticate tumor hypoxia, e.g., ALDOA is part of the HNSCC hypoxia gene signature of refs. 14,15. This evidence concerns the gene ALDOA and head and neck squamous cell carcinoma.